Skip to Main Content

Advertisement

Skip Nav Destination

Abstract LB-160: ITRI-260, a promising candidate for treatment of acute myeloid leukemia

Cancer Res (2010) 70 (8_Supplement): LB-160.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal